In a third, follow-up study, the group surmised that CCR7 activation turned on the Notch1 signaling pathway with concomitant elevation of the cancer stem cell population and thus loss of CCR7 produced attenuated Notch1 responses, reduced stem cell numbers and slowed tumor formation and growth [79]. The gene discussed is CCR7; the disease is neoplasm.